Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
1(17%)
Results Posted
200%(2 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_1
3
50%
Ph phase_2
1
17%

Phase Distribution

3

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(1)
Terminated(3)
Other(1)

Detailed Status

Terminated2
Active, not recruiting1
Completed1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
33.3%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (75.0%)
Phase 21 (25.0%)

Trials by Status

active_not_recruiting117%
completed117%
withdrawn117%
unknown117%
terminated233%

Recent Activity

1 active trials
Showing 5 of 6
terminatedphase_1

A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

NCT05886491
active_not_recruitingphase_2

A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT05020015
terminatedphase_1

A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

NCT04501614
completed

Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?

NCT06921252
withdrawnphase_1

A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)

NCT06377228
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05886491Phase 1

A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

Terminated
NCT05020015Phase 2

A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Active Not Recruiting
NCT04501614Phase 1

A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Terminated
NCT06921252

Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?

Completed
NCT06377228Phase 1

A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)

Withdrawn
NCT00166790

Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6